Sep. 11 at 1:19 PM
$PAVM PAVmed Q2 2025 net loss of
$13.3M (
$0.74/share). Subsidiary Veris Health raised
$2.5M to chase FDA clearance on an implantable monitor, while a letter of intent was signed for esophageal imaging tech. R&D pipelines & fresh capital—still a long road to relevance.
#SG Sweetgreen’s luxury athleisure lifestyle setting: bright & clean interior, crisp greens, bright wooden textures (post-class vibe) is reinforcing the
$18 level. Where energized femininity resonates.
#XHB Homebuilder demand trends & housing supply dynamics are reinforcing the
$128 level. Fed rate-cut speculation & “golden cross” approaching.
#BTC Bitcoin’s on-chain metrics & institutional flows are propping up the
$114,000 level. Fed rate-cut speculation & “liquidity expansion.”
